—THC
— • —
$189.64
P/E
12.24
PEG
—
FCF Yield
—
Rev Growth YoY
+312.0% YoY
Gross Margin
8226.0%
Health Score
4/10
D/E Ratio
3.12
Confidence
LOW
Business Snapshot
The ticker symbol and company name are absent from this payload, which limits contextual framing. Based on the available data — a current price of $189.64, a Price/Sales ratio of 0.8x, and a P/E of 12.24x — this appears to be a revenue-heavy business operating in an unspecified sector and industry. Without a confirmed market capitalisation figure, cap-tier classification cannot be determined with certainty.
Financial Health
Score: 4/10
The financial picture is deeply contradictory. On the surface, margins appear extraordinary — a reported gross margin of 8,226% and a net margin of 660% — but figures of this magnitude almost certainly reflect data anomalies or accounting distortions rather than genuine operational performance, and should be treated with extreme caution...
Risk Assessment
- DATA INTEGRITY: Gross margin of 8,226% and net margin of 660% are statistically implausible for any normal operating business and suggest possible data errors or non-standard accounting classifications that undermine financial analysis.
- EARNINGS COLLAPSE: Earnings growth of -5,191% year-over-year signals a severe deterioration in profitability despite strong revenue expansion — a classic red flag for margin compression or one-time distortions.
- LEVERAGE: Debt/Equity of 3.12x indicates a heavily leveraged balance sheet; with free cash flow unavailable, the ability to service this debt cannot be assessed.
- TECHNICAL WEAKNESS: A confirmed death cross (50-day MA crossing below 200-day MA) alongside a bearish MACD signal indicates negative price momentum across both short- and medium-term timeframes.
- MISSING FUNDAMENTALS: TTM Revenue, TTM Net Income, Free Cash Flow, and DCF fair value are all absent, creating a material gap in the analytical foundation required for confident valuation.
---...
**Score: 4/10** The financial picture is deeply contradictory. On the surface, margins appear extraordinary — a reported gross margin of 8,226% and a net margin of 660% — but figures of this magnitude almost certainly reflect data anomalies or accounting distortions rather than genuine operational performance, and should be treated with extreme caution. The balance sheet carries a Debt/Equity ratio of 3.12x, indicating a highly leveraged capital structure that amplifies financial risk. Free cash flow is unavailable, removing the single most important measure of whether the business actually generates cash to service that debt. ---
- **DATA INTEGRITY:** Gross margin of 8,226% and net margin of 660% are statistically implausible for any normal operating business and suggest possible data errors or non-standard accounting classifications that undermine financial analysis. - **EARNINGS COLLAPSE:** Earnings growth of -5,191% year-over-year signals a severe deterioration in profitability despite strong revenue expansion — a classic red flag for margin compression or one-time distortions. - **LEVERAGE:** Debt/Equity of 3.12x indicates a heavily leveraged balance sheet; with free cash flow unavailable, the ability to service this debt cannot be assessed. - **TECHNICAL WEAKNESS:** A confirmed death cross (50-day MA crossing below 200-day MA) alongside a bearish MACD signal indicates negative price momentum across both short- and medium-term timeframes. - **MISSING FUNDAMENTALS:** TTM Revenue, TTM Net Income, Free Cash Flow, and DCF fair value are all absent, creating a material gap in the analytical foundation required for confident valuation. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives